1/11/2012

The Foundation for the National Institutes of Health Biomarkers Consortium has made available the biomarker data resulting from a proteomics study aimed at improving the diagnosis and evaluation of Alzheimer's disease. The study uncovered biomarkers from cerebrospinal fluid samples obtained from the Alzheimer's Disease Neuroimaging Initiative.

Related Summaries